Mantle Cell Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Mantle Cell Lymphoma
    • Decatur, Alabama
    • +53 more
    2022-03-04
    Mar 4, 2022
    M
    Active, not recruiting
    • Mantle Cell Lymphoma
    • Untreated
    • Basking Ridge, New Jersey
    • +6 more
    2022-02-17
    Feb 17, 2022
    B
    Terminated
    • Mantle Cell Lymphoma
    • +4 more
    • cellular immunotherapy
    • Providence, Rhode Island
    • +1 more
    2022-02-23
    Feb 23, 2022
    C
    Recruiting
    • Melanoma
    • +25 more
    • Scottsdale, Arizona
    • +10 more
    2022-02-25
    Feb 25, 2022
    U
    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • +12 more
      • Bedford, Bedfordshire, United Kingdom
      • +8 more
      2022-02-22
      Feb 22, 2022
      K
      Not yet recruiting
      • Mantle Cell Lymphoma
      • RB/RBAC alternating
      • RB
      • Seoul, Gangnam-Gu, Korea, Republic of
        Samsung Medical Center
      2022-02-08
      Feb 8, 2022
      M
      Recruiting
      • Acute Lymphoblastic Leukemia
      • +12 more
      • Anti-Thymocyte Globulin
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      2022-02-08
      Feb 8, 2022
      U
      Recruiting
      • Multiple Myeloma
      • +11 more
      • Pre-biotic foods/drinks
      • Charlottesville, Virginia
        University of Virginia
      2022-02-14
      Feb 14, 2022
      N
      Recruiting
      • MCL
      • Mantle Cell Lymphoma
      • Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
      • Odense, Denmark
      • +21 more
      2022-02-11
      Feb 11, 2022
      S
      Active, not recruiting
      • B Cells-Tumors
      • +4 more
      • Idelalisib 100 MG
      • Placebo Oral Tablet
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      2022-02-10
      Feb 10, 2022
      E
      Recruiting
      • CCND1 Positive
      • +2 more
      • Atlanta, Georgia
      • +2 more
      2022-02-09
      Feb 9, 2022
      S
      Recruiting
      • Mantle Cell Lymphoma
      • Venetoclax Oral Tablet [Venclexta]
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      2022-02-10
      Feb 10, 2022
      V
      Recruiting
      • Chronic Lymphocytic Leukemia
      • +11 more
      • Zilovertamab vedotin
      • Duarte, California
      • +13 more
      2022-02-08
      Feb 8, 2022
      M
      Active, not recruiting
      • Mantle Cell Lymphoma
      • Lymphoma
      • BR-I (bendamustine, rituximab, ibrutinib)
      • VEN (Venetoclax)
      • Basking Ridge, New Jersey
      • +6 more
      2022-02-03
      Feb 3, 2022
      C
      Recruiting
      • Waldenstrom Macroglobulinemia
      • +8 more
      • Iopofosine I 131 single dose
      • +2 more
      • Redlands, California
      • +20 more
      2022-01-21
      Jan 21, 2022
      W
      Active, not recruiting
      • Mantle Cell Lymphoma
      • Saint Louis, Missouri
        Washington University School of Medicine
      2022-02-02
      Feb 2, 2022
      M
      Completed
      • Mantle Cell Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      2022-01-27
      Jan 27, 2022
      H
      Recruiting
      • Acute Myeloid Leukemia
      • +17 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center & Research Institute
      2022-01-26
      Jan 26, 2022
      M
      Completed
      • Mantle Cell Lymphoma
      • +6 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +8 more
      • Houston, Texas
        M D Anderson Cancer Center
      2022-01-18
      Jan 18, 2022
      N
      Recruiting
      • Lymphoma, Non-Hodgkin
      • +9 more
      • NKX019
      • Denver, Colorado
      • +6 more
      2022-01-19
      Jan 19, 2022
      L
      Recruiting
      • Chronic Lymphocytic Leukemia
      • +5 more
      • Scottsdale, Arizona
      • +55 more
      2022-01-12
      Jan 12, 2022
      P
      Recruiting
      • Chronic Lymphocytic Leukemia
      • +4 more
      • Acalabrutinib 2x100 MG Oral Capsule + alloSCT
      • Warszawa, Mazowieckie, Poland
      • +5 more
      2021-12-23
      Dec 23, 2021